Karin Haraldsson

669 total citations
9 papers, 295 citations indexed

About

Karin Haraldsson is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Karin Haraldsson has authored 9 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Hematology. Recurrent topics in Karin Haraldsson's work include BRCA gene mutations in cancer (4 papers), Acute Myeloid Leukemia Research (3 papers) and Multiple Myeloma Research and Treatments (3 papers). Karin Haraldsson is often cited by papers focused on BRCA gene mutations in cancer (4 papers), Acute Myeloid Leukemia Research (3 papers) and Multiple Myeloma Research and Treatments (3 papers). Karin Haraldsson collaborates with scholars based in Sweden, United States and Bangladesh. Karin Haraldsson's co-authors include Åke Borg, Óskar Þór Jóhannsson, Håkan Olsson, Qiuxia Zhang, Niklas Loman, Alexandre Puissant, Jianmin Sun, Lars Rönnstrand, Johan Vallon‐Christersson and Eugenia Cordero and has published in prestigious journals such as Blood, Cancer Research and Oncogene.

In The Last Decade

Karin Haraldsson

8 papers receiving 288 citations

Peers

Karin Haraldsson

GENET

MB

PHEOH

HEMAT

PFM

Masutaka Tokuda Japan

Fátima Vaz Portugal

Blanche P. Alter United States

Jean Christophe Bories France

S. Larkins United Kingdom

Nona Shayegi Germany

Patrycja Wawrzyniecka United Kingdom

Natalina Elliott United States

Peter Gambell Australia

Samuel John United States

Masutaka Tokuda Japan

Karin Haraldsson

93 ×0.6

GENET

121 ×0.9

MB

153 ×1.5

PHEOH

57 ×0.8

HEMAT

47 ×1.0

PFM

Citations per year, relative to Karin Haraldsson Karin Haraldsson (= 1×) peers Masutaka Tokuda

Countries citing papers authored by Karin Haraldsson

Since Specialization

Citations

This map shows the geographic impact of Karin Haraldsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Haraldsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Haraldsson more than expected).

Fields of papers citing papers by Karin Haraldsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Haraldsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Haraldsson. The network helps show where Karin Haraldsson may publish in the future.

Co-authorship network of co-authors of Karin Haraldsson

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Haraldsson. A scholar is included among the top collaborators of Karin Haraldsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Haraldsson. Karin Haraldsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Öfverholm, Anna, Therese Törngren, Anna Rosén, et al.. (2023). Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer. BMC Cancer. 23(1). 738–738. 5 indexed citations

2.

Cordero, Eugenia, Alexandre Puissant, Jianmin Sun, et al.. (2016). Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML. Oncogene. 35(39). 5119–5131. 96 indexed citations

3.

Cordero, Eugenia, Alexandre Puissant, Nuzhat N. Kabir, et al.. (2016). Abstract 310: Mechanism of sorafenib resistance in acute myeloid leukemia. Cancer Research. 76(14_Supplement). 310–310. 1 indexed citations

4.

Puissant, Alexandre, Nuzhat N. Kabir, Jianmin Sun, et al.. (2015). Aberrant Activation of the PI3K/mTOR Pathway Promotes Resistance to Sorafenib in AML. Blood. 126(23). 2472–2472.

5.

Gustafsson, Erika, Anna Rosén, Karin Barchan, et al.. (2009). Directed evolution of chemotaxis inhibitory protein of Staphylococcus aureus generates biologically functional variants with reduced interaction with human antibodies. Protein Engineering Design and Selection. 23(2). 91–101. 10 indexed citations

6.

Gustafsson, Erika, et al.. (2008). Purification of truncated and mutated Chemotaxis Inhibitory Protein of Staphylococcus aureus—an anti-inflammatory protein. Protein Expression and Purification. 63(2). 95–101. 11 indexed citations

7.

Syrjäkoski, Kirsi, Tuula Kuukasjärvi, Kati K. Waltering, et al.. (2004). BRCA2 Mutations in 154 Finnish Male Breast Cancer Patients. Neoplasia. 6(5). 541–545. 32 indexed citations

8.

Brożek, Izabela, Karin Haraldsson, Therese Sandberg, et al.. (2003). BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern Poland. Human Mutation. 21(5). 553–554. 31 indexed citations

9.

Haraldsson, Karin, Niklas Loman, Qiuxia Zhang, et al.. (1998). BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease.. PubMed. 58(7). 1367–71. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact